New Agents in Chronic Lymphocytic Leukemia: A Practical Guide

EP. 1: Prognostic Factors and the Impact of New Therapies

January 19th 2016

EP. 2: Detecting Chromosomal Abnormalities in CLL

January 19th 2016

EP. 3: Front-Line Chemoimmunotherapy in CLL

January 19th 2016

EP. 4: Clinical Objectives in Chronic Lymphocytic Leukemia Treatment

January 19th 2016

EP. 5: The Value of CT Scans in Chronic Lymphocytic Leukemia

January 19th 2016

EP. 6: Chemoimmunotherapy in Chronic Lymphocytic Leukemia

January 19th 2016

EP. 7: CD-20 Antibodies in Chronic Lymphocytic Leukemia

January 19th 2016

EP. 8: The Role of Ofatumumab in the Treatment of CLL

January 19th 2016

EP. 9: Small-Molecule Inhibitors: Ibrutinib in CLL

January 19th 2016

EP. 10: Using Ibrutinib in Chronic Lymphocytic Leukemia

January 19th 2016

EP. 11: Pharmacovigilance with Ibrutinib in CLL

January 19th 2016

EP. 12: Mechanisms of Ibrutinib Resistance in CLL

January 19th 2016

EP. 13: Evaluating the Role of Idelalisib in CLL

January 19th 2016

EP. 14: Venetoclax in Chronic Lymphocytic Leukemia

January 19th 2016

EP. 15: Emerging Chronic Lymphocytic Leukemia Therapies

January 19th 2016